Table 2.
Performance of ARR based on different PAC detection methods for PA screening.
| Optimal cut-off | Sensitivity (95 % CI) | Specificity (95 % CI) | PPV (95 % CI) | NPV (95 % CI) | |
|---|---|---|---|---|---|
| ARRPAC (CLIA, ng/dL)/DRC (CLIA, ng/dL) | 30.0 | 0.930 (0.809–0.985) | 0.918 (0.819–0.973) | 0.889 (0.775–0.949) | 0.949 (0.862–0.982) |
| ARRPAC (LC-MS/MS, ng/dL)/DRC (CLIA, ng/dL) | 20.0 | 0.930 (0.809–0.985) | 0.896 (0.798–0.942) | 0.883 (0.761–0.930) | 0.946 (0.855–0.981) |
ARR, aldosterone-to-renin ratio; CI, confidence interval; CLIA, chemiluminescence immunoassay; DRC, direct renin concentration; LC-MS/MS, liquid chromatography with tandem mass spectrometry; NPV, negative predictive value; PAC, plasma aldosterone concentration; PPV, positive predictive value.